GeoVax Labs

Yahoo Finance • 2 years ago

GeoVax Reports 2023 First Quarter Financial Results and Provides Corporate Update

Cancer Gene Therapy Program and Next-Generation COVID-19 Vaccine Advancing in Phase 2 Clinical Trials Company to Host Conference Call and Webcast Todayat 4:30 p.m. ET ATLANTA, GA, May 04, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire– Geo... Full story

Yahoo Finance • 2 years ago

GeoVax Reports 2022 Year-End Financial Results and Provides Corporate Update

Company Expands Ongoing Clinical Trials and the Breadth and Capacity of Its Novel Vaccine Platform Technology ATLANTA, GA, March 23, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire - GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company... Full story

Yahoo Finance • 2 years ago

GeoVax Receives Notice of Allowance for Zika Vaccine Patent

Preclinical Evaluation Demonstrated 100% Protection Against a Lethal Dose of Zika Virus ATLANTA, GA, Jan. 25, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherap... Full story